KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcosa (ACA) Capital Expenditures (2017 - 2025)

Arcosa's Capital Expenditures history spans 9 years, with the latest figure at $64.2 million for Q4 2025.

  • For Q4 2025, Capital Expenditures rose 20.45% year-over-year to $64.2 million; the TTM value through Dec 2025 reached $165.6 million, down 12.7%, while the annual FY2025 figure was $165.6 million, 12.7% down from the prior year.
  • Capital Expenditures for Q4 2025 was $64.2 million at Arcosa, up from $39.6 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $64.2 million in Q4 2025 and bottomed at $19.3 million in Q3 2021.
  • The 5-year median for Capital Expenditures is $37.0 million (2024), against an average of $39.1 million.
  • The largest annual shift saw Capital Expenditures surged 114.4% in 2022 before it tumbled 41.6% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at $24.3 million in 2021, then soared by 114.4% to $52.1 million in 2022, then grew by 12.67% to $58.7 million in 2023, then dropped by 9.2% to $53.3 million in 2024, then increased by 20.45% to $64.2 million in 2025.
  • Per Business Quant, the three most recent readings for ACA's Capital Expenditures are $64.2 million (Q4 2025), $39.6 million (Q3 2025), and $27.8 million (Q2 2025).